Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells
Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells
复制标题
糖皮质激素在肠道 L 细胞转录水平上减少胰高血糖素样肽-1 的产生
DOI:
10.1016/j.mce.2015.02.014
复制
发表时间:
2015
影响因子:
4.1
通讯作者:
Noriyasu Hirasawa
中科院分区:
文献类型:
--
作者:
Taiki Sato;Hiroto Hayashi;Masahiro Hiratsuka;Noriyasu Hirasawa
Glucocorticoids are widely used as anti-inflammatory or immunosuppressive drugs, but often induce hyperglycemia as a side effect. Glucagon-like peptide-1 (GLP-1) is secreted from intestinal L cells and plays crucial roles in maintaining glucose homeostasis. However, the direct effects of glucocorticoids on the GLP-1 production pathway in L cells remain unclear. We investigated the effects of glucocorticoids on GLP-1 productionin vitroandin vivo. In L cell lines, glucocorticoids decreased GLP-1 release and expression of the precursor, proglucagon, at protein and mRNA levels, which were inhibited by mifepristone. The administration of dexamethasone or budesonide to mice significantly decreased the mRNA expression of proglucagon in the ileum and partially decreased glucose-stimulated GLP-1 secretion. Compound A, a dissociated glucocorticoid receptor modulator, did not affect the expression of proglucagonin vitro. These results suggested that glucocorticoids directly reduced GLP-1 production at the transcriptional level in L cells through a glucocorticoid receptor dimerization-dependent mechanism.